SCHEMBL26193350

SCHEMBL26193350

Cn1ccc(-c2cc(Cl)ncc2C2CCCC2)n1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ JMJD6 Q6NYC1 2/20 0.42
▸ BMPR1A P36894 1/20 0.38
▸ ACVRL1 P37023 1/20 0.38
▸ ACVR1 Q04771 1/20 0.38
▸ IRAK4 Q9NWZ3 5/20 0.37
▸ IRAK1 P51617 4/20 0.37
▸ LRRK2 Q5S007 1/20 0.37
▸ ABCG2 Q9UNQ0 1/20 0.37
▸ ALOX5AP P20292 1/20 0.37
▸ FEN1 P39748 1/20 0.37
▸ MAPK10 P53779 2/20 0.35
▸ CREBBP Q92793 2/20 0.35
▸ CYP17A1 P05093 1/20 0.34
▸ S1PR2 O95136 1/20 0.34
▸ DRD2 P14416 1/20 0.34
▸ CGAS Q8N884 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31512085 0.94 JMJD6 (0.38) JMJD6BMPR1AACVRL1ACVR1IRAK4
SCHEMBL31512068 0.78 ALOX5AP (0.43) JMJD6BMPR1AACVRL1ACVR1IRAK4
SCHEMBL26193347 0.77 JMJD6 (0.37) JMJD6BMPR1AACVRL1ACVR1IRAK4
SCHEMBL26193404 0.77 BMPR1A (0.40) JMJD6BMPR1AACVRL1ACVR1IRAK4
SCHEMBL25261218 0.77 HPGDS (0.42) JMJD6ALOX5APFEN1
SCHEMBL26193402 0.76 JMJD6 (0.36) JMJD6BMPR1AACVRL1ACVR1IRAK4
SCHEMBL26193351 0.74 JMJD6 (0.40) JMJD6BMPR1AACVRL1ACVR1IRAK4
SCHEMBL30510170 0.74 S1PR2 (0.38) JMJD6IRAK4MAPK10CREBBPS1PR2
SCHEMBL25302815 0.74 S1PR2 (0.38) JMJD6IRAK4MAPK10CREBBPS1PR2
Hydrochloric Acid SCHEMBL31415289 0.71 KEAP1 (0.44) JMJD6BMPR1AACVRL1ACVR1IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2024-07-09 — — US disclosed
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD KU LEUVEN R&D (BE) 2023-09-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 JMJD6 916/4885BMPR1A 2383/4885ACVRL1 2371/4885
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 JMJD6 916/4885BMPR1A 2383/4885ACVRL1 2371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback